Mackay, I. M. & Arden, K. E. MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 12, 222 (2015).

PubMed  PubMed Central  Article  Google Scholar 

Stadler, K. et al. SARS–beginning to understand a new virus. Nat. Rev. Microbiol. 1, 209–218 (2003).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Umakanthan, S. et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad. Med. J. 96, 753–758 (2020).

CAS  PubMed  Google Scholar 

Hu, B., Guo, H., Zhou, P. & Shi, Z. L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141–154 (2021).

CAS  PubMed  Article  Google Scholar 

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).

Article  Google Scholar 

Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kirtipal, N., Bharadwaj, S. & Kang, S. G. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect. Genet. Evol. 85, 104502 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang, M. Y. et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front. Cell Infect. Microbiol. 10, 587269 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jaworski, J. P. Neutralizing monoclonal antibodies for COVID-19 treatment and prevention. Biomed. J. 44, 7–17 (2021).

CAS  PubMed  Article  Google Scholar 

Oran, D. P. & Topol, E. J. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann. Intern. Med. 174, 655–662 (2021).

PubMed  Article  Google Scholar 

Sharma, A., Ahmad Farouk, I. & Lal, S. K. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses 13, 202 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Woo, P. C. et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J. Virol. 86, 3995–4008 (2012).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl Acad. Sci. USA 101, 6212–6216 (2004).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Llanes, A. et al. Betacoronavirus genomes: how genomic information has been used to deal with past outbreaks and the COVID-19 pandemic. Int. J. Mol. Sci. 21, 4546 (2020).

CAS  PubMed Central  Article  Google Scholar 

Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141–1149 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Li, M. Y., Li, L., Zhang, Y. & Wang, X. S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9, 45 (2020).

PubMed  PubMed Central  Article  Google Scholar 

de Wit, E., van Doremalen, N., Falzarano, D. & Munster, V. J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523–534 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254 (2013).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Li, W. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: a structural biophysical perspective. Biophys. Chem. 264, 106420 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bestle, D. et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance 3, e202000786 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Bayati, A., Kumar, R., Francis, V. & McPherson, P. S. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 296, 100306 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Moog, C. et al. Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques. Mucosal Immunol. 7, 46–56 (2014).

CAS  PubMed  Article  Google Scholar 

Cheeseman, H. M. et al. Broadly neutralizing antibodies display potential for prevention of HIV-1 infection of mucosal tissue superior to that of nonneutralizing antibodies. J. Virol. 91, e01762-16 (2017).

PubMed  Article  Google Scholar 

Tan, G. S. et al. Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathog. 12, e1005578 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Yang, F. et al. Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus. Emerg. Microbes Infect. 9, 664–675 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Alter, G. & Moody, M. A. The humoral response to HIV-1: new insights, renewed focus. J. Infect. Dis. 202, S315–S322 (2010).

CAS  PubMed  Article  Google Scholar 

Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369, 650–655 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Suryadevara, N. et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell 184, 2316–2331 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Liu, L. et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature 584, 450–456 (2020). This article describes the isolation of a panel of SARS-Co-2 NTD-targeting and RBD-targeting nAbs summarized in this Review.

CAS  PubMed  Article  Google Scholar 

Cerutti, G. et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe 29, 819–833 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lok, S. M. An NTD supersite of attack. Cell Host Microbe 29, 744–746 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130–135 (2021).

CAS  PubMed  Article  Google Scholar 

McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332–2347 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cerutti, G. et al. Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain. Cell Rep. 37, 109928 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang, X. et al. Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies. Emerg. Microbes Infect. 11, 477–481 (2022).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ai, J. et al. Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages. Cell Host Microbe 30, 1077–1083 (2022).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Makdasi, E. et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 36, 109679 (2021).

CAS